Found: 26
Select item for more details and to access through your institution.
IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1356300
- By:
- Publication type:
- Article
Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection.
- Published in:
- Pathology International, 2023, v. 73, n. 1, p. 39, doi. 10.1111/pin.13288
- By:
- Publication type:
- Article
Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 6, p. 860, doi. 10.1007/s12185-022-03320-0
- By:
- Publication type:
- Article
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8<sup>+</sup> T cells in hematogenous metastasis model with lymphocyte infusion.
- Published in:
- Clinical & Experimental Metastasis, 2022, v. 39, n. 2, p. 335, doi. 10.1007/s10585-021-10135-6
- By:
- Publication type:
- Article
Anti-VEGF antibody triggers the effect of anti-PD-L1 antibody in PD-L1<sup>low</sup> and immune desert-like mouse tumors.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93113-y
- By:
- Publication type:
- Article
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model.
- Published in:
- Clinical & Experimental Metastasis, 2020, v. 37, n. 1, p. 199, doi. 10.1007/s10585-019-10008-z
- By:
- Publication type:
- Article
T2∗ Relaxation Time Obtained from Magnetic Resonance Imaging of the Liver Is a Useful Parameter for Use in the Construction of a Murine Model of Iron Overload.
- Published in:
- Contrast Media & Molecular Imaging, 2019, p. 1, doi. 10.1155/2019/7463047
- By:
- Publication type:
- Article
Sustained effect of continuous treatment with bevacizumab following bevacizumab in combination with chemotherapy in a human ovarian clear cell carcinoma xenograft model.
- Published in:
- Oncology Reports, 2019, v. 42, n. 3, p. 1057, doi. 10.3892/or.2019.7211
- By:
- Publication type:
- Article
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft model.
- Published in:
- Oncology Letters, 2017, v. 14, n. 4, p. 4197, doi. 10.3892/ol.2017.6679
- By:
- Publication type:
- Article
Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 2, p. 425, doi. 10.3892/ijo.2017.4036
- By:
- Publication type:
- Article
The effect of frequency of C.E.R.A. administration on the contribution of dietary iron for erythropoiesis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
- Published in:
- Oncology Reports, 2016, v. 36, n. 2, p. 626, doi. 10.3892/or.2016.4902
- By:
- Publication type:
- Article
Antitumor activity of alectinib, a selective ALK inhibitor, in an ALK-positive NSCLC cell line harboring G1269A mutation: Efficacy of alectinib against ALK G1269A mutated cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reduction of a marker of oxidative stress with enhancement of iron utilization by erythropoiesis activation following epoetin beta pegol administration in iron-loaded db/db mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 4, p. 1024, doi. 10.1002/ijc.29848
- By:
- Publication type:
- Article
Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 5, p. 987, doi. 10.3892/mco.2015.609
- By:
- Publication type:
- Article
Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 4, p. 638, doi. 10.1007/s10120-013-0329-8
- By:
- Publication type:
- Article
Erratum to: Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 5, p. 561, doi. 10.1007/s12185-014-1554-6
- By:
- Publication type:
- Article
Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice.
- Published in:
- International Journal of Hematology, 2012, v. 96, n. 6, p. 692, doi. 10.1007/s12185-012-1217-4
- By:
- Publication type:
- Article
Renoprotection by Continuous Erythropoietin Receptor Activator in Puromycin Aminonucleoside-Induced Nephrotic Syndrome.
- Published in:
- American Journal of Nephrology, 2012, v. 36, n. 5, p. 419, doi. 10.1159/000343493
- By:
- Publication type:
- Article
Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
- Published in:
- Clinical & Experimental Metastasis, 2011, v. 28, n. 7, p. 649, doi. 10.1007/s10585-011-9398-4
- By:
- Publication type:
- Article
Increased mobilization of c-kit<sup>+</sup> Sca-1<sup>+</sup> Lin<sup>-</sup> (KSL) cells and colony-forming units in spleen (CFU-S) following de novo formation of a stem cell niche depends on dynamic, but not stable, membranous ossification.
- Published in:
- Journal of Cellular Physiology, 2006, v. 208, n. 1, p. 188, doi. 10.1002/jcp.20652
- By:
- Publication type:
- Article
Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity.
- Published in:
- Toxicologic Pathology, 2003, v. 31, n. 6, p. 665, doi. 10.1080/01926230390244924
- By:
- Publication type:
- Article